Every patient undergoing ovulation stimulation is at risk of developing ovarian hyperstimulation syndrome (OHSS). The most significant risk factor for OHSS is polycystic ovarian syndrome (PCOS). The degree of the follicular response to the ovulation-stimulating drugs is related to the severity of OHSS. To gain detailed insights into “OHSS: A Distressing Complication in PCOS Treatment”, join the renowned expert Gynecologist Dr.
Ameet Patki , in our exclusive session, on 6 th February 2025, 6:00 PM IST onwards . Stay tuned! Suggested for you Polycystic Ovarian Syndrome (PCOS): Knowing it Better PCOS: Dietary Recommendations ##Disclaimer## The content provided on Docplexus is intended for educational purposes only. While we strive to ensure its accuracy, we make no warranties, explicit or implied, about the suitability, reliability, or adequacy of the information, including data…
